Dr. Jeong led academic research in immuno-oncotherapy as a medical school professor, and also demonstrated technical expertise and leadership as Head of R&D in the life sciences industry, especially in the antibody, CAR-T, ADC, and vaccine fields. His most recent leadership role was at Eutilex Pharmaceuticals/its subsidiary Pantilogous as CTO/CEO. Dr. Jeong received his Ph.D. at the Microbiology and Immunology (Viral Oncology) in the University of Oklahoma Health Sciences Center, successfully finished his post-doctoral fellowship at the Dana-Farber Cancer Institute (Medical Oncology) in Harvard Medical School, and served as faculty member in the USC Keck Medical School, Medical College of Wisconsin (Dermatology and Urology), and Seoul National University.
This person is not in any teams
This person is not in any offices